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A 54-year-old male patient was hospitalized on 
March 1, 2005, with complaints of right hypochondral-
gia and anorexia. His elder brother underwent an op-
eration for bladder carcinoma at the age of 57 years. 
There was no other noteworthy history of disease in 
his family. He had received surgical intervention to re-
move his left eye in December 1998. At the time of 
hospitalization, his disease was unidentified. He had no 
history of excessive consumption of alcoholic beverag-
es, but had a continued habit of smoking 20 cigarettes 
a day for 34 years. Measured on admission, he was 173 
cm in height, weighed 54 kg, remained clearly con-
scious, and had a blood pressure of 132/69 mmHg, a 
regular pulse beat of 65/min., and a body temperature 
of 37.3℃. There was no anemia in the eye conjunctiva 
and no icterus. There was no appreciable findings in 
the neck, the chest, and the four limbs. The pulmo-
nary/hepatic boundary was between the 4th and 5th 
ribs. The abdomen was hard and swollen. The liver 
was palpable under the right hypochondriac region at 
the position of 8 lateral fingers. Laboratory studies on 
????????????
Hepatic metastasis of malignant melanoma tends to 
have a poor prognosis. It has been reported that the 
average survival period ranges from 4 to 8 months af-
ter a metastatic focus has been diagnosed 1, 2）. When 
melanoma is classified by the site of metastasis, a he-
patic metastasis has a poorer prognosis at a statistical-
ly significant level than a dermal or lymph node metas-
tasis 3, 4）. Up to now there have been 5 reported cases 
of deaths caused by fulminant liver failure 5〜9）. In the 
present study we describe the case of malignant mela-
noma of the choroid membrane, which was found to 
have developed from multiple hepatic metastases 6 
years after the enucleation of the left eye ball and for 
which we had difficulty making a diagnosis. 
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???????
In Europe and the United States, uveal melanoma involving the choroid membrane is the most commonly 
occurring intraocular malignancy in adults. Hepatic metastasis of uveral melanoma tends to have a poor 
prognosis. In the present study we describe the case of malignant melanoma of the choroid membrane, 
which was found to have developed from multiple hepatic metastases 6 years after the enucleation of the 
left eye ball. In metastatic hepatic tumor patients whose primary focus is unknown, it is important to con-
duct a detailed investigation of the patient’s disease history, bearing the present findings on uveal melanoma 
in mind.
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sonography （Fig. 3）. The left branch of the portal vein 
was patent, but the right branch was occluded due to 
pressure from the tumors. There was no dilatation of 
the intra- and extrahepatic bile duct. No tumor was 
observed in the gall bladder, the pancreas, other or-
gans inside the abdominal cavity, and in the peritone-
um. The chest CT showed an old inflammatory change 
in the upper lung fields of both lungs and a pulmonary 
emphysema image, but did not reveal any tumor. 
Esophago-gastroduodenoscopy detected erosive gastri-
tis in the antrum and colonoscopy did not reveal any 
appreciably abnormal findings. Systemic galium scin-
admission were as follows：hemoglobin 11.2 g/dl, white 
blood cell count 3830 cells/mm3, platet count 429,000 
cells/mm3, alanine amonitransferase （ALT） 126 U/l, 
aspartate amonotransferase （AST） 112 U/l, alkaline 
phosphatase （ALP） 221 U/l, gamma-glutamyl trans-
peptidase （GGT） 446 U/l, lactate dehydrogenase 
（LDH） 911 U/l, total bilirubin 0.5 mg/dl, albumin 3.5 g/
dl. Viral serology screen was negative for hepatitis B 
surface antigen and anti-hepatitis C virus.
Chest radiograph showed a mild degree of pulmo-
nary emphysema. Abdominal radiograph showed that 
the enlarged liver had brought pressure on the intesti-
nal tract and excluded intestinal gases in the left 
downward direction （Fig. 1）. Abdominal ultrasonogra-
phy showed that the liver had enlarged markedly and 
that tumors had occurred in many places throughout 
the entire liver. The tumors exhibited bull’s eye signs 
or cluster signs, which are findings that match those of 
metastatic liver tumors （Fig. 2）. Contrast computed 
tomography （CT） showed liver tumors with a ring-
shape contrast, thereby suggesting metastatic liver tu-
mors, similar to the findings of the abdominal ultra-
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??????　 Abdominal radiograph showing the movement of 
intestinal gases in the left, downward direction 
caused by the enlarged liver.
??????　 Abdominal ultrasonography showing many 
recurring hyperechoic tumors in the liver. These 
tumors have a bull’s eye sign or a cluster sign, 
which indicates metastatic liver tumors.
??????　 Contrasted computed tomography showing 
multiple liver tumors enhanced in a ring shape. 
The left branch of the portal vein was patent, but 
the right branch was occluded by the tumors.
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ment （Fig. 6）. When this pigment was bleached by a 
melanin-bleaching method, the disease was diagnosed 
as hepatic metastasis of a histopathologically malignant 
melanoma （Fig. 7）. On admission of this patient, we at-
tempted to contact the hospital where he had received 
the operation for his eye lesion in 1998. After we con-
ducted a tumor biopsy, that hospital sent a report, 
which indicated that the eye lesion had been diagnosed 
as a malignant melanoma of the left choroid mem-
brane. Recurrence and distant metastasis had not been 
clearly observed in the systemic examination conduct-
ed in July 2003. After the established diagnosis, serum 
5-S-cysteinyldopa （5-S-CD） revealed a markedly in-
creased level of 293.3 nmol/l （normal 1.5 to 8.0 nmol/l）. 
tigraphy showed abnormal accumulation only in the 
enlarged liver （Fig. 4）. but systemic bone scintillation 
did not yield results suggestive of abnormal accumula-
tion （Fig. 5）. Magnetic resonance imaging （MRI） was 
not performed because of his claustrophobia. A tumor 
biopsy under ultrasonic guidance was carried out on 
March 14 for the purpose of histological diagnosis be-
cause it was not possible to diagnose any primary fo-
cus from imaging tests and tumor markers. Moreover, 
there were no abnormal findings in the fields of otorhi-
nolaryngology and urology. Macroscopic observation 
revealed that the collected specimens had a black col-
or. Hematoxylin and eosin staining showed solid 
growth of atypical cells associated with a brown pig-
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??????　 Systemic galium scintigraphy showed abnormal 
accumulation only in the enlarged liver, but no 
accumulation in other organs.
??????　 Systemic bone scintigraphy gave no result of 
abnormal accumulation.
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cases （93.8％） among 145 cases of metastatic uveal 
melanoma 14）. 
5-S-cysteinyldopa （5-S-CD） is an index for melano-
genesis 15）. There are reports that 5-S-CD is useful for 
the diagnosis of melanoma and for the prognostic cal-
culation of those cases involving distant metastasis 16〜
18）. In our case, the level of 5-S-CD was substantially 
elevated to 293.3 nmol/l at the time of diagnosis. Al-
though this level tended to decrease due to treatment 
with anticancer drug injections, the patient died on the 
117th day after the first medical examination. 
There is no established therapy for melanoma in-
volving hepatic metastasis. In cases of melanoma that 
has spread to organs within the abdominal cavity, it 
has been reported that patients from whom the meta-
static focus has been radically resected should have a 
prolonged survival period 19）. Rivoire et al. 20） investi-
gated 63 cases of therapeutic results from uveal mela-
noma involving hepatic metastasis, and reported that 
cases who had undergone a radical resection yielded 
good prognostic results. The authors of this report fol-
lowed up 602 cases of post-operative uveal melanoma 
by conducting abdominal ultrasonic tests at 6-month 
intervals, and detected 63 cases of hepatic metastasis 
in 14 years. Even though ultrasonography was con-
ducted every 6 months, there were only 14 cases of 
hepatic metastasis in whom radical resection had been 
possible. Accordingly, surgical treatment is generally 
considered to be difficult. In 1998, Carrasco et al. re-
Arterial injection therapies were conducted three 
times, utilizing 100 mg of cisplatin. After the first injec-
tion, serum 5-S-CD decreased slightly to 159.6 nmol/l, 
but after the second treatment, the patient’s general 
condition worsened. The patient died on June 25 from 
the complication of disseminated intravascular coagula-
tion syndrome that developed on June 14. A pathologi-
cal autopsy could not be conducted because family 
consent was not given.
??????????
In Europe and the United States, uveal melanoma in-
volving the choroid membrane is the most commonly 
occurring intraocular malignancy in adults. It arises 
from uveal melanocytes residing in the uveal stroma, 
and accounts for 70％ of all primary ocular cancers. It 
occurs at the frequency of 0.7 persons per 100,000 peo-
ple of the population in Europe 10）. In Asia, it occurs at 
the frequency of 0.02 persons per 100,000 people of the 
population of India 11）. Uveal melanoma is reported to 
have a better prognosis than other types of melanoma, 
but there have been few reports in which the long-
term prognosis has been investigated. Kujala et al. re-
ported that the uveal melanoma death rate is 31％ in 5 
years, 45％ in 15 years, 49％ in 25 years, and 52％ in 
35 years, and concluded that distant metastasis exag-
gerates prognosis 12）. Because the distant metastasis of 
uveal melanoma is hematogenous, the liver is the fre-
quent destination of distant metastasis 13）. Gragoudas et 
al. reported that hepatic metastases accounted for 136 
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??????　 Hematoxylin and eosin staining showed solid 
growth of atypical cells with a brown pigment. 
??????　 The pigment was bleached by a melanin-bleaching 
method, the disease was diagnosed as hepatic 
metastasis of a histopathologically malignant 
melanoma.
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